Highlights Aprogen Biologics Inc.

Equities

A003060

KR7003060001

Pharmaceuticals

End-of-day quote Korea S.E. Other stock markets 2026-03-06			5-day change	1st Jan Change
294.00 ^KRW	+0.34%		-10.37%	-43.35%

Nov. 13	Aprogen Biologics Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025	CI
25-10-23	Aprogen Biologics Inc. announced that it has received KRW 15 billion in funding from APTN Inc.	CI

Highlights

Nov. 13	Aprogen Biologics Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025	CI
25-08-13	Aprogen Biologics Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2025	CI
25-05-21	Aprogen Medicines Inc. agreed to acquire an additional 20.06% stake in AP Healthcare Inc. from Aprogen Biologics Inc. for KRW 58.4 billion.	CI
25-05-14	Aprogen Biologics Inc. Reports Earnings Results for the First Quarter Ended March 31, 2025	CI
25-03-14	Aprogen Biologics Inc. Reports Earnings Results for the Full Year Ended December 31, 2024	CI
24-11-13	Aprogen Biologics Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024	CI
24-08-14	Aprogen Biologics Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2024	CI
24-07-22	An undisclosed buyer agreed to acquire 6.87% stake in Aprogen Biologics Inc. from Aprogen Medicines Inc. for KRW 43.9 billion.	CI
24-05-14	Aprogen Biologics Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
24-03-13	Aprogen Biologics Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI
23-11-13	Aprogen Biologics Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	CI
23-08-14	Aprogen Biologics Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	CI
23-05-12	Aprogen Biologics Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	CI
22-12-30	Aprogen pharmaceuticals,Inc. completed the acquisition of Aprogen Biologics Inc. from Aprogen, Inc.	CI
22-11-11	Aprogen Biologics Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	CI
22-10-03	Aprogen pharmaceuticals,Inc. agreed to acquire Aprogen Biologics Inc. from Aprogen, Inc.	CI
22-08-12	Aprogen pharmaceuticals,Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	CI
22-05-13	Aprogen pharmaceuticals,Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022	CI
22-03-14	Aprogen pharmaceuticals,Inc. Reports Earnings Results for the Full Year Ended December 31, 2021	CI
21-11-11	Aprogen pharmaceuticals,Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	CI
21-04-14	Immunotech Biopharm : Hires Aprogen Director as New Tech Chief	MT
21-01-13	Aprogen KIC Inc. cancelled the acquisition of additional 5.6% stake in Aprogen pharmaceuticals,Inc..	CI
20-01-13	Aprogen KIC Inc. agreed to acquire additional 5.6% stake in Aprogen pharmaceuticals,Inc. for KRW 17.8 billion.	CI
19-09-29	Aprogen pharmaceuticals,Inc. acquired an additional 6.38% stake in Locojoy International Corporation from Aprogen Biologics Inc. for KRW 7 billion.	CI
19-06-11	Aprogen Kic Inc cancelled the acquisition of 49.37% stake in Aprogen Biologics Inc from Aprogen pharmaceuticals,Inc. and Aprogen, Inc.	CI